Skip to main content
. 2016 Aug 31;10(8):e0004969. doi: 10.1371/journal.pntd.0004969

Table 2. PRNT50 titers against rCd#1 and rMACV (serum dilution 1:30–1:960).

MCg1-infected PRNT50 titer to MCg2-infected PRNT50 titer to MCg3-infected PRNT50 titer to
mice rCd#1 rMACV Mice rCd#1 rMACV mice rCd#1 rMACV
# 1 1:480 (d331) 1:30 (d33) # 8 >1:960 ND # 15 1:480 ND
# 2 >1:960 1:240 # 9 1:480 ND # 16 >1:960 ND
# 3 >1:960 (d33) ND3 (d33) # 10 >1:960 ND # 17 >1:960 ND
# 4 >1:960 1:120 # 11 >1:960 ND # 18 >1:960 ND
# 5 >1:960 (d33) 1:60 (d33) # 12 >1:960 ND # 19 >1:960 ND
# 6 >1:960 1:120 # 13 >1:960 ND # 20 1:240 ND
# 7 >1:960 ND # 14 >1:960 ND # 21 >1:960 ND
Geometric mean2 >1:869.5 1:90.9 Geometric mean >1:869.5 ND Geometric mean >1:713.3 ND

Table 2: The PRNT titers to rCd#1 and rMACV of the serum samples from MCg1-, MCg2- and MCg3-infected mice were measured.

1) Numbers in parentheses indicates the day after infection. If not indicated, the subject survived until 42 dpi.

2) Geometric mean of the PRNT titers. The geometric mean of the PRNT titers of sera from rMACV-infected animals is 1:60.0 against rCd#1 and is below the detection level against rMACV. The geometric mean of the PRNT from rCd#1-infected animals is >1:762.0 against rCd#1 and not detectable level against rMACV. These PRNT titers against rMACV from rMACV- and rCd#1-infected control groups were reported previously [16].

3) ND: not detectable, <1:30